The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck

Head and Neck

Volumn 22, Issue 4, 2000, Pages 317-322

  Hall, Stephen F ^a   Groome, Patti A ^a   Rothwell, Deanna ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Comorbidity; Expected survival; Head and neck cancer; Survival analysis

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CANCER MORTALITY; CANCER SURVIVAL; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEAD CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ACTUARIAL ANALYSIS; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; ONTARIO; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SURVIVAL ANALYSIS;

EID: 0034096354     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200007)22:4<317::AID-HED1>3.0.CO;2-0     Document Type: Article

References (20)

1. Medlog Clinical Data Management System, Information Analysis Corp, Incline Village, NV.
2. SAS Proprietary Software, release 6.12 1996. Cary, NC: SAS Institute Inc.
3. Statistics Canada.
4. Canadian Institute of Actuaries. http//www.actuaries.ca
5. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. National Cancer Institute Monograph 1961;6:101-121.
6. L Burke. Smoking levels settle on a high plateau. Can Med Assoc J 1998;158:152.
7. Feinstein AR, Schimpff CR, Andrews JF, Wells CK. Cancer of the larynx: a new staging system and a reappraisal of prognosis and treatment. J Chron Dis 1977;30: 277-305.
8. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Ann Otol Rhinol Laryngol 1994;103:83-92.
9. Pugliano FA, Piccirillo JF, Zequeira MR, Emani B, et al. Clinical-severity staging system for oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 1997;123: 1118-1124.
10. Pugliano FA, Piccirillo JF, Zequeira MR, Fredrickson JM, et al. Clinical-severity staging system for oral cavity cancer. Otolaryngol Head Neck Surg 1999;120:38-45.
11. Kaplan MH, Feinstem AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
12. Blot WJ, McLaughlin JK, Winn DM, Austin DF, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-3287.
13. Wald NJ, Hackshaw AK. Cigarette smoking: an epidemiologic overview. Tobacco and Health, Br Med Bull 1996;52: 3-11.
14. Andre K, Schraub S, Mercier M, Bontemps P. Role of alcohol and tobacco in the etiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer 1995;31B (oral oncology):301-309.
15. Deleyiannis FW-B, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with H&N cancer. J Natl Cancer Inst 1996;88:27-44.
16. Selzer ML. The Michigan Alcoholism Screening Test. Am J Psychiat 1971;127:1653-1658.
17. Poikolainien K. Alcohol and mortality: a review. J Clin Epidemiol 1995;48:455-465.
18. Dyer AR, Stamler J, Paul O, Lepper M, et al. Alcohol consumption and 17 year mortality in the Chicago Western Electric Co Study. Prev Med 1980;9:78-90.
19. Jones AS, Morar P, Phillips DE, Field JK, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-1353.
20. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-112.